ReviewSeminars in immunopathology2019

Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: minimal residual disease and cure?

Hans Carl Hasselbalch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.